dc.contributor.author |
Tongkobpetch S. |
|
dc.contributor.author |
Rungsiwiwut R. |
|
dc.contributor.author |
Pruksananonda K. |
|
dc.contributor.author |
Suphapeetiporn K. |
|
dc.contributor.author |
Shotelersuk V. |
|
dc.date.accessioned |
2021-04-05T03:02:47Z |
|
dc.date.available |
2021-04-05T03:02:47Z |
|
dc.date.issued |
2019 |
|
dc.identifier.issn |
18735061 |
|
dc.identifier.other |
2-s2.0-85069590379 |
|
dc.identifier.uri |
https://ir.swu.ac.th/jspui/handle/123456789/12322 |
|
dc.identifier.uri |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85069590379&doi=10.1016%2fj.scr.2019.101493&partnerID=40&md5=4e1ce5eee7a33b41e23cb8f86cf3a22a |
|
dc.description.abstract |
Two clones of human induced pluripotent stem cells (iPSCs) were generated from dermal fibroblasts isolated from a one-year-old Thai patient with X-linked osteogenesis imperfecta. The patient harbored a mutation, p.N459S, in the MBTPS2 gene. The cells were reprogrammed using an integration-free Sendai virus containing KLF4, c-MYC, OCT4 and SOX2. Both of the established iPSC lines (MDCUi001-A and MDCUi001-B) maintained normal karyotype, expressed pluripotent markers and differentiated into all three germ layers. © 2019 |
|
dc.subject |
afp1 protein |
|
dc.subject |
alpha smooth muscle actin |
|
dc.subject |
beta tubulin |
|
dc.subject |
cell marker |
|
dc.subject |
genomic DNA |
|
dc.subject |
glyceraldehyde 3 phosphate dehydrogenase |
|
dc.subject |
kruppel like factor 4 |
|
dc.subject |
membrane bound transcription factor peptidase site 2 |
|
dc.subject |
Myc protein |
|
dc.subject |
octamer transcription factor 4 |
|
dc.subject |
peptidase |
|
dc.subject |
rex1 protein |
|
dc.subject |
tra 1 60 protein |
|
dc.subject |
tra 1 81 protein |
|
dc.subject |
transcription factor |
|
dc.subject |
transcription factor NANOG |
|
dc.subject |
transcription factor Sox2 |
|
dc.subject |
unclassified drug |
|
dc.subject |
kruppel like factor |
|
dc.subject |
kruppel like factor 4 |
|
dc.subject |
Myc protein |
|
dc.subject |
MYC protein, human |
|
dc.subject |
SOX2 protein, human |
|
dc.subject |
transcription factor Sox |
|
dc.subject |
Article |
|
dc.subject |
cell clone |
|
dc.subject |
cell differentiation |
|
dc.subject |
cell reprogramming technique |
|
dc.subject |
child |
|
dc.subject |
controlled study |
|
dc.subject |
ectoderm |
|
dc.subject |
embryoid body |
|
dc.subject |
endoderm |
|
dc.subject |
human |
|
dc.subject |
human cell |
|
dc.subject |
in vitro study |
|
dc.subject |
induced pluripotent stem cell |
|
dc.subject |
karyotype |
|
dc.subject |
male |
|
dc.subject |
mdcui001 a cell line |
|
dc.subject |
mdcui001 b cell line |
|
dc.subject |
mesoderm |
|
dc.subject |
nonhuman |
|
dc.subject |
nuclear reprogramming |
|
dc.subject |
osteogenesis imperfecta |
|
dc.subject |
pluripotent stem cell line |
|
dc.subject |
point mutation |
|
dc.subject |
preschool child |
|
dc.subject |
priority journal |
|
dc.subject |
Sendai virus |
|
dc.subject |
short tandem repeat |
|
dc.subject |
skin fibroblast |
|
dc.subject |
Thai (people) |
|
dc.subject |
cell line |
|
dc.subject |
cytology |
|
dc.subject |
fibroblast |
|
dc.subject |
genetics |
|
dc.subject |
induced pluripotent stem cell |
|
dc.subject |
metabolism |
|
dc.subject |
osteogenesis imperfecta |
|
dc.subject |
physiology |
|
dc.subject |
Sendai virus |
|
dc.subject |
Thailand |
|
dc.subject |
Cell Differentiation |
|
dc.subject |
Cell Line |
|
dc.subject |
Fibroblasts |
|
dc.subject |
Humans |
|
dc.subject |
Induced Pluripotent Stem Cells |
|
dc.subject |
Karyotype |
|
dc.subject |
Kruppel-Like Transcription Factors |
|
dc.subject |
Male |
|
dc.subject |
Osteogenesis Imperfecta |
|
dc.subject |
Proto-Oncogene Proteins c-myc |
|
dc.subject |
Sendai virus |
|
dc.subject |
SOXB1 Transcription Factors |
|
dc.subject |
Thailand |
|
dc.title |
Generation of two human iPSC lines (MDCUi001-A and MDCUi001-B) from dermal fibroblasts of a Thai patient with X-linked osteogenesis imperfecta using integration-free Sendai virus |
|
dc.type |
Article |
|
dc.rights.holder |
Scopus |
|
dc.identifier.bibliograpycitation |
Stem Cell Research. Vol 39, (2019) |
|
dc.identifier.doi |
10.1016/j.scr.2019.101493 |
|